On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...
The past 12 months recorded several medical breakthroughs, including first-time gene therapy outcomes, notable FDA approvals and virtual healthcare delivery, ABC News reported Dec. 30. Here are seven ...
Northwestern is launching an institute to catalyze the translation of groundbreaking University research discoveries into treatments and devices that improve patients’ lives. The Querrey-Simpson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results